Turnstone Biologics Corp Common Stock

Quarterly Financials

Values in thousands 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Revenue
$0
$0
$0
$0
Gross Profit
-500
-509
EBITDA
-11,041
-17,877
-21,559
-20,182
EBIT
-11,378
-18,368
-22,057
-20,691
Net Income
-12,872
-17,032
-21,304
-19,629
Net Change In Cash
0
0
0
0
Free Cash Flow
-16,457
-17,484
-16,122
-17,604
Cash
28,926
24,133
17,517
14,433
Basic Shares
23,128
23,037
23,037
23,011

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$19,306
$73,300
$101,293
Gross Profit
16,506
71,100
99,281
EBITDA
-72,494
-56,234
-28,493
35,713
EBIT
-59,032
-30,693
33,701
Net Income
-70,837
-55,200
-30,834
33,269
Net Change In Cash
0
19,306
73,300
101,293
Free Cash Flow
-67,667
-67,401
-76,232
-49,035
Cash
28,926
17,798
34,731
123,381
Basic Shares
23,037
11,562
22,188
22,188

Earnings Calls

Quarter EPS
2025-03-31
-$0.55
2024-12-31
-$0.56
2024-09-30
-$0.74
2024-06-30
-$0.92